Close
  • Latest News
  • Artificial Intelligence
  • Video
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Logo
Subscribe
Logo
  • Latest News
  • Artificial Intelligence
  • Video
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Subscribe
    Home Latest News
    • Mobile

    Mobile Pillbox App Promotes Diabetes Medication Adherence: Report

    Written by

    Brian T. Horowitz
    Published July 16, 2013
    Share
    Facebook
    Twitter
    Linkedin

      eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More.

      MediSafe Project, which offers a medication adherence cloud-based mobile platform, has released data claiming a medication adherence rate of around 80 percent for patients relying on its mobile app for reminders to take their type 2 diabetes medication.

      The app reminds users when they need to take medication and sends an alert to a family member, friend or caregiver if a dose is missed. MediSafe Project aggregates data on patient behavior and physician trends to study how patients take their medication.

      When using the pillbox app, patients had 80 percent adherence when taking sitagliptin, a antihyperglycemic drug, and an 82 percent adherence with Januvia, a brand name version of sitagliptin, MediSafe Project reported on July 15.

      Other results included 79 percent for diabetes drug Glucophage and 76 percent compliance rate with Kombiglyze, as well as a 78 percent rate for metformin, the generic version of those two drugs. MediSafe Project also reported a 77 percent compliance rate for patients taking Onglyza, another diabetes drug that helps control blood sugar.

      “The results from these self-reported adherence rates prove that the combination of a mobile reminder and the support of family/friends works,” MediSafe Project CEO Omri “Bob” Shor told eWEEK in an email.

      Caregivers can monitor patient data from the company’s cloud platform. When patients indicate that they’ve taken their medication, the app sends the encrypted data through a connection protected by Secure Sockets Layer (SSL) and stores it on servers compliant with the Health Insurance Portability and Accountability Act (HIPAA). The data is then synced back to the caregiver, Shor noted.

      “The MediSafe Project provides users with convenience and routine by reminding people to take their medications, and tracking that they actually take them,” Shor said.

      Type 2 diabetes causes patients to be resistant to insulin and can be treated with oral medication.

      Forgetfulness leads to 30 percent of medication nonadherence, according to Shor. Another problem is a lack of support from others, Shor said.

      Despite the existence of products such as MediSafe Project, only 7 percent of caregivers use online or mobile tools to track how patients take medications and refill prescriptions, according to a June 20 report by the Pew Internet and American Life Project.

      MediSafe Project reported successful use of the app by caregivers, which are the company’s “most retained users,” Shor said.

      “Over 18 percent of our users started using MediSafe Project by caring for patients or loved ones,” Shor said, noting that caregivers then began using the app themselves after seeing successful use by patients.

      Compliance rates were more than 26 percent higher for type 2 diabetic users when they used mobile technology than they were for general medication adherence to long-term therapies, MediSafe Project noted.

      General medication adherence rates for long-term therapies were 50 percent, according to the World Health Organization.

      Rates were higher with mobile tools due to the portability advantages, according to Shor.

      “The engagement a person has with his/her mobile device is much higher than with their medication,” Shor said. “The mobile device goes with him/her anywhere, and helps the patient manage his/her lifestyle. Using a mobile phone for medication reminders shows high results, while the caretaker/family connectivity mimics real-life family support, increasing the engagement even further.”

      Brian T. Horowitz
      Brian T. Horowitz
      Brian T. Horowitz is a technology and health writer as well as a copy editor. Brian has worked on the tech beat since 1996 and covered health care IT and rugged mobile computing for eWEEK since 2010. He has contributed to more than 20 publications, including Computer Shopper, Fast Company, FOXNews.com, More, NYSE Magazine, Parents, ScientificAmerican.com, USA Weekend and Womansday.com, as well as other consumer and trade publications.

      Get the Free Newsletter!

      Subscribe to Daily Tech Insider for top news, trends & analysis

      Get the Free Newsletter!

      Subscribe to Daily Tech Insider for top news, trends & analysis

      MOST POPULAR ARTICLES

      Artificial Intelligence

      9 Best AI 3D Generators You Need...

      Sam Rinko - June 25, 2024 0
      AI 3D Generators are powerful tools for many different industries. Discover the best AI 3D Generators, and learn which is best for your specific use case.
      Read more
      Cloud

      RingCentral Expands Its Collaboration Platform

      Zeus Kerravala - November 22, 2023 0
      RingCentral adds AI-enabled contact center and hybrid event products to its suite of collaboration services.
      Read more
      Artificial Intelligence

      8 Best AI Data Analytics Software &...

      Aminu Abdullahi - January 18, 2024 0
      Learn the top AI data analytics software to use. Compare AI data analytics solutions & features to make the best choice for your business.
      Read more
      Latest News

      Zeus Kerravala on Networking: Multicloud, 5G, and...

      James Maguire - December 16, 2022 0
      I spoke with Zeus Kerravala, industry analyst at ZK Research, about the rapid changes in enterprise networking, as tech advances and digital transformation prompt...
      Read more
      Video

      Datadog President Amit Agarwal on Trends in...

      James Maguire - November 11, 2022 0
      I spoke with Amit Agarwal, President of Datadog, about infrastructure observability, from current trends to key challenges to the future of this rapidly growing...
      Read more
      Logo

      eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site’s focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Advertisers

      Advertise with TechnologyAdvice on eWeek and our other IT-focused platforms.

      Advertise with Us

      Menu

      • About eWeek
      • Subscribe to our Newsletter
      • Latest News

      Our Brands

      • Privacy Policy
      • Terms
      • About
      • Contact
      • Advertise
      • Sitemap
      • California – Do Not Sell My Information

      Property of TechnologyAdvice.
      © 2024 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.